首页>
外国专利>
Combination of regorafenib and pd-1/pd-l1(2) inhibitors for treating cancer
Combination of regorafenib and pd-1/pd-l1(2) inhibitors for treating cancer
展开▼
机译:瑞格非尼与pd-1 / pd-1(2)抑制剂的组合治疗癌症
展开▼
页面导航
摘要
著录项
相似文献
摘要
The present invention relates to pharmaceutical compositions and combinations comprising regorafenib or its hydrate, solvate, metabolite or pharmaceutically acceptable salt or a polymorph thereof and a PD-1/PD-L1(2) inhibitor for treating, preventing or managing diseases and conditions including hyperproliferative disorders such as cancer in humans and other mammals.
展开▼